| Name | Title | Contact Details |
|---|
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.
Regal Medical Group is dedicated to delivering high quality of care with an emphasis of continuously improving service quality. Some of the benefits of being a Regal Provider are the tools and support we give the providers to effectively care for the
Midwest Group is a Glen Ellyn, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SeniorWell is a pioneer in mobile healthcare, providing on-site audiology, dentistry, optometry and podiatry services to nursing facilities across the Midwest. SeniorWell team members have over 20 years of industry experience dedicated to serving residents of long-term care facilities.
Genesis Medical Imaging, Inc. is a Huntley, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.